← Leaderboards
Roy A. Jensen
Vanderbilt University
$20,860,843
Attributed
$20,860,843
Total exposure
22
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.2M · FY2012–25$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,315,216 · 23
By mechanism
P30$46,369,236 · 20
C06$8,000,000 · 1
R01$945,980 · 1
U54$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cancer Center Support Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$253,882,416
- Mary L. Disis · University Of Washington$91,856,641
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$87,214,340
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$79,061,055
- Robert J Gray · Dana-Farber Cancer Institute$78,329,401
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
Research focus
Cancer Center Support GrantCancer CenterMalignant NeoplasmsProgramsResource SharingUniversitiesKansasFundingMemberResearch PersonnelLeadershipTranslational ResearchClinical ResearchLaboratoriesDrug DiscoveryInstitutionBaseClinical TrialsCancer PreventionGrantEnsureInstructionFosteringCommunities
Grant awards (136)
The University of Kansas Cancer Center$2,808,770
P30 · FY2025 · CA · contact PI
Leadership, Planning & Evaluation$395,408
P30 · FY2025 · CA · contact PI
The University of Kansas Cancer Center$2,808,765
P30 · FY2024 · CA · contact PI
Leadership, Planning & Evaluation$395,408
P30 · FY2024 · CA · contact PI
University of Kansas Cancer Center Midwest Pre-Clinical Imaging Center$8,000,000
C06 · FY2023 · OD · contact PI
The University of Kansas Cancer Center$2,808,760
P30 · FY2023 · CA · contact PI
Leadership, Planning & Evaluation$395,408
P30 · FY2023 · CA · contact PI
The University of Kansas Cancer Center$2,822,506
P30 · FY2022 · CA · contact PI
Leadership, Planning & Evaluation$395,408
P30 · FY2022 · CA · contact PI
P30 CATCH UP Above Accrual Goal Administrative Supplement Request$192,654
P30 · FY2022 · CA · contact PI
The University of Kansas Cancer Center$115,000
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$2,271,814
P30 · FY2021 · CA · contact PI
Developmental Funds$367,573
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2021 · CA · contact PI
Planning and Evaluation$22,510
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$2,272,619
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$765,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$497,280
P30 · FY2020 · CA · contact PI
Developmental Funds$389,221
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$150,980
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$75,167
P30 · FY2020 · CA · contact PI
Planning and Evaluation$22,510
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$2,273,410
P30 · FY2019 · CA · contact PI
Developmental Funds$410,458
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$100,000
P30 · FY2019 · CA · contact PI
Planning and Evaluation$22,520
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$2,399,981
P30 · FY2018 · CA · contact PI
Developmental Funds$452,927
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$225,000
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$199,855
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$61,059
P30 · FY2018 · CA · contact PI
Planning and Evaluation$23,775
P30 · FY2018 · CA · contact PI
Planning and Evaluation$16,668
P30 · FY2018 · CA · contact PI
Developmental Funds$16,668
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$16,666
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$2,351,214
P30 · FY2017 · CA · contact PI
Developmental Funds$451,411
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$56,642
P30 · FY2017 · CA · contact PI
Developmental Funds$47,564
P30 · FY2017 · CA · contact PI
Planning and Evaluation$22,537
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$6,368
P30 · FY2017 · CA · contact PI
Planning and Evaluation$2,486
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$2,124,747
P30 · FY2016 · CA · contact PI
Senior Leadership$1,018,903
P30 · FY2016 · CA · contact PI
Developmental Funds$282,558
P30 · FY2016 · CA · contact PI
Biostatistics and Informatics Shared Resource$210,326
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$157,232
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$124,999
P30 · FY2016 · CA · contact PI
Clinical Trials Management Shared Resource$109,328
P30 · FY2016 · CA · contact PI
Cancer Center Administration$108,646
P30 · FY2016 · CA · contact PI
Lead Development and Optimization Shared Resource$83,325
P30 · FY2016 · CA · contact PI
Drug Discovery, Delivery and Experimental Therapeutics$72,885
P30 · FY2016 · CA · contact PI
Biospecimen Shared Resource$62,895
P30 · FY2016 · CA · contact PI
Cancer Control and Population Health$61,792
P30 · FY2016 · CA · contact PI
Cancer Biology$36,443
P30 · FY2016 · CA · contact PI
Cancer Prevention$36,443
P30 · FY2016 · CA · contact PI
Planning and Evaluation$29,191
P30 · FY2016 · CA · contact PI
Protocol Review and Monitoring System$12,012
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$1,510,000
P30 · FY2015 · CA · contact PI
Senior Leadership$727,872
P30 · FY2015 · CA · contact PI
Developmental Funds$198,737
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$179,698
P30 · FY2015 · CA · contact PI
Biostatistics and Informatics Shared Resource$147,933
P30 · FY2015 · CA · contact PI
Clinical Trials Management Shared Resource$76,896
P30 · FY2015 · CA · contact PI
Cancer Center Administration$76,416
P30 · FY2015 · CA · contact PI
Lead Development and Optimization Shared Resource$58,606
P30 · FY2015 · CA · contact PI
Drug Discovery, Delivery and Experimental Therapeutics$51,263
P30 · FY2015 · CA · contact PI
Biospecimen Shared Resource$44,237
P30 · FY2015 · CA · contact PI
Cancer Control and Population Health$43,462
P30 · FY2015 · CA · contact PI
Cancer Prevention$25,632
P30 · FY2015 · CA · contact PI
Cancer Biology$25,632
P30 · FY2015 · CA · contact PI
Planning and Evaluation$20,532
P30 · FY2015 · CA · contact PI
Protocol Review and Monitoring System$12,782
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$1,510,000
P30 · FY2014 · CA · contact PI
Senior Leadership$727,872
P30 · FY2014 · CA · contact PI
Developmental Funds$198,737
P30 · FY2014 · CA · contact PI
Biostatistics and Informatics Shared Resource$147,933
P30 · FY2014 · CA · contact PI
Clinical Trials Management Shared Resource$76,896
P30 · FY2014 · CA · contact PI
Cancer Center Administration$76,416
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$75,000
P30 · FY2014 · CA · contact PI
Lead Development and Optimization Shared Resource$58,606
P30 · FY2014 · CA · contact PI
Drug Discovery, Delivery and Experimental Therapeutics$51,263
P30 · FY2014 · CA · contact PI
Biospecimen Shared Resource$44,237
P30 · FY2014 · CA · contact PI
Cancer Control and Population Health$43,462
P30 · FY2014 · CA · contact PI
Cancer Prevention$25,632
P30 · FY2014 · CA · contact PI
Cancer Biology$25,632
P30 · FY2014 · CA · contact PI
Planning and Evaluation$20,532
P30 · FY2014 · CA · contact PI
Protocol Review and Monitoring System$12,782
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$1,306,547
P30 · FY2013 · CA · contact PI
Senior Leadership$629,800
P30 · FY2013 · CA · contact PI
Developmental Funds$171,960
P30 · FY2013 · CA · contact PI
Biostatistics and Informatics Shared Resource$128,001
P30 · FY2013 · CA · contact PI
Planning and Evaluation$75,000
P30 · FY2013 · CA · contact PI
Cancer Center Support Grant$75,000
P30 · FY2013 · CA · contact PI
Clinical Trials Management Shared Resource$66,535
P30 · FY2013 · CA · contact PI
Cancer Center Administration$66,120
P30 · FY2013 · CA · contact PI
Lead Development and Optimization Shared Resource$50,709
P30 · FY2013 · CA · contact PI
Drug Discovery, Delivery and Experimental Therapeutics$44,356
P30 · FY2013 · CA · contact PI
Biospecimen Shared Resource$38,277
P30 · FY2013 · CA · contact PI
Cancer Control and Population Health$37,606
P30 · FY2013 · CA · contact PI
Cancer Biology$22,179
P30 · FY2013 · CA · contact PI
Cancer Prevention$22,178
P30 · FY2013 · CA · contact PI
Planning and Evaluation$17,765
P30 · FY2013 · CA · contact PI
Protocol Review and Monitoring System$11,060
P30 · FY2013 · CA · contact PI
Cancer Center Support Grant$1,397,375
P30 · FY2012 · CA · contact PI
Senior Leadership$673,582
P30 · FY2012 · CA · contact PI
Developmental Funds$183,914
P30 · FY2012 · CA · contact PI
Biostatistics and Informatics Shared Resource$136,900
P30 · FY2012 · CA · contact PI
Clinical Trials Management Shared Resource$71,161
P30 · FY2012 · CA · contact PI
Cancer Center Administration$70,716
P30 · FY2012 · CA · contact PI
Lead Development and Optimization Shared Resource$54,235
P30 · FY2012 · CA · contact PI
Drug Discovery, Delivery and Experimental Therapeutics$47,440
P30 · FY2012 · CA · contact PI
Biospecimen Shared Resource$40,938
P30 · FY2012 · CA · contact PI
Cancer Control and Population Health$40,220
P30 · FY2012 · CA · contact PI
Cancer Biology$23,720
P30 · FY2012 · CA · contact PI
Cancer Prevention$23,720
P30 · FY2012 · CA · contact PI
Planning and Evaluation$19,000
P30 · FY2012 · CA · contact PI
Protocol Review and Monitoring System$11,829
P30 · FY2012 · CA · contact PI
MMTV-BRCA1 MODELS$246,197
R01 · FY2003 · CA
MMTV-BRCA1 MODELS$239,604
R01 · FY2002 · CA
Pilot--AH receptor in human breast tumors$0
U54 · FY2002 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2002 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2002 · CA
MMTV-BRCA1 MODELS$233,197
R01 · FY2001 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2001 · CA
Pilot--AH receptor in human breast tumors$0
U54 · FY2001 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2001 · CA
MMTV-BRCA1 MODELS$226,982
R01 · FY2000 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2000 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2000 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2000 · CA
Core--Human tissue acquisition/pathology$0
P30 · FY2000 · CA